title: Matrix metalloproteinase-2 contributes to increased platelet reactivity in patients with metastatic prostate cancer: a preliminary study.
authors.affiliation: Department of Medical Oncology, Cross Cancer Institute and Department of Oncology, University of Alberta, Edmonton, AB, Canada T6G 2H7. Paul.K.Jurasz@uth.tmc.edu
authors.forename: Paul
authors.initials: P
authors.lastname: Jurasz
authors.forename: Scott
authors.initials: S
authors.lastname: North
authors.forename: Peter
authors.initials: P
authors.lastname: Venner
authors.forename: Marek W
authors.initials: MW
authors.lastname: Radomski
mesh_terms: D000368:Aged; D014408:Biomarkers, Tumor / Q000097:blood*; D001792:Blood Platelets / Q000378:metabolism*; D006801:Humans; D008297:Male; D020778:Matrix Metalloproteinase 2 / Q000097:blood* / Q000378:metabolism; D008875:Middle Aged; D009362:Neoplasm Metastasis; D015539:Platelet Activation; D011471:Prostatic Neoplasms / Q000097:blood* / Q000201:enzymology*; D018570:Risk Assessment / Q000379:methods*
chemical_list: D014408:Biomarkers, Tumor; D020778:Matrix Metalloproteinase 2